Insulet Corp. (PODD)
152.48
+3.19
(+2.14%)
USD |
NASDAQ |
Nov 13, 16:00
152.75
+0.27
(+0.18%)
After-Hours: 19:59
Insulet Total Liabilities (Quarterly) : 1.836B for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.836B |
| June 30, 2026 | 1.743B |
| March 31, 2026 | 1.685B |
| December 31, 2025 | 1.675B |
| September 30, 2025 | 1.645B |
| June 30, 2025 | 2.006B |
| March 31, 2025 | 2.187B |
| December 31, 2024 | 1.876B |
| September 30, 2024 | 1.907B |
| June 30, 2024 | 1.883B |
| March 31, 2024 | 1.833B |
| December 31, 2023 | 1.856B |
| September 30, 2023 | 1.860B |
| June 30, 2023 | 1.832B |
| March 31, 2023 | 1.786B |
| December 31, 2022 | 1.775B |
| September 30, 2022 | 1.738B |
| June 30, 2022 | 1.691B |
| March 31, 2022 | 1.622B |
| December 31, 2021 | 1.492B |
| September 30, 2021 | 1.501B |
| June 30, 2021 | 1.465B |
| March 31, 2021 | 1.255B |
| December 31, 2020 | 1.269B |
| September 30, 2020 | 1.116B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.063B |
| March 31, 2020 | 1.049B |
| December 31, 2019 | 1.067B |
| September 30, 2019 | 1.118B |
| June 30, 2019 | 727.94M |
| March 31, 2019 | 728.98M |
| December 31, 2018 | 716.64M |
| September 30, 2018 | 688.38M |
| June 30, 2018 | 659.71M |
| March 31, 2018 | 659.20M |
| December 31, 2017 | 658.23M |
| September 30, 2017 | 426.09M |
| June 30, 2017 | 394.60M |
| March 31, 2017 | 381.37M |
| December 31, 2016 | 393.50M |
| September 30, 2016 | 388.10M |
| June 30, 2016 | 235.60M |
| March 31, 2016 | 228.38M |
| December 31, 2015 | 241.08M |
| September 30, 2015 | 237.99M |
| June 30, 2015 | 230.14M |
| March 31, 2015 | 224.97M |
| December 31, 2014 | 218.33M |
| September 30, 2014 | 220.86M |
| June 30, 2014 | 247.44M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | 19.59B |
| Abbott Laboratories | 56.62B |
| TransMedics Group, Inc. | 967.22M |
| The Cooper Cos., Inc. | 4.345B |
| Stryker Corp. | 23.79B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.415B |
| Shareholders Equity (Quarterly) | 1.579B |
| Debt to Equity Ratio | 0.6093 |
| Current Ratio | 2.473 |
| Net Debt Paydown Yield | 1.01% |